glaxo aim high profit fall glaxosmithkline saw profit fall 9 last year 62bn 115bn europe big drugmaker say recovery 2005 way cheap copy drug particularly antidepressant paxil wellbutrin weak dollar hit profit global sale 1 2004 firm confident new drug pipeline will deliver profit despite failure obesity drug chief executive jeanpierre garnier say difficult year early afternoon trade london company share price 1 1218 penny mr garnier say company absorbed 15bn lose sale generic still manage grow business continue success key product mean can now look forward good performance 2005 say 2005 will also important year term research development pipeline progress however firm discontinue development experimental treatment obesity know 771 disappoint clinical trial result glaxo rely new treatment condition cancer diabetes depression hivaids allergy lift pace sale growth several disappoint year 